Digital biomarkers and artificial intelligence: a new frontier in personalized management of inflammatory bowel disease

Digital biomarkers and artificial intelligence: a new frontier in personalized management of inflammatory bowel disease

Background and aimsArtificial intelligence (AI) is rapidly gaining traction in gastroenterology, particularly in the management of inflammatory bowel disease (IBD). Given the complexity of IBD care, AI offers the potential to enhance diagnosis, monitoring, and treatment. This review aims to summariz...

Full description

Saved in:
Bibliographic Details
Main Authors: Diletta De Deo, Arianna Dal Buono, Roberto Gabbiadini, Olga Maria Nardone, Rocio Ferreiro-Iglesias, Giuseppe Privitera, Cristiana Bonifacio, Manuel Barreiro-de Acosta, Cristina Bezzio, Alessandro Armuzzi
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-08-01
Series:Frontiers in Immunology
Subjects:
artificial intelligence
inflammatory bowel disease
machine learning
digital biomarkers
personalized medicine artificial neural network
APR: algorithm-predicted remission
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1637159/full
Tags: Add Tag
No Tags, Be the first to tag this record!
Login for hold and recall information

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2025.1637159/full

Similar Items